Stryker price target raised to $68 from $63 at RW Baird Baird raised its price target on Stryker following Q4 results. The firm cited improving end market demand in the orthopedic market, increased market share, and new product launches. Shares are Outperform rated.
News For SYK From The Last 14 Days
Check below for free stories on SYK the last two weeks.
Stryker upcoming analyst day may be catalyst for shares, says Argus Argus believes Stryker is well positioned to post stronger sales and earnings in the second half of the year as new products launch and surgical volume rebounds. The firm thinks the company's analyst day on September 17 could be a catalyst for the shares and it maintains its Buy rating and $102 price target on the stock.